Health Care & Life Sciences » Pharmaceuticals | Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
Stock Exchange Mexican Stock Exchange
EPS
MXN68.06
Market Cap
MXN196.1 B
Shares Outstanding
1.02 B
Public Float
-
Teva Pharmaceutical Industries Ltd. ADR
Stock Exchange New York Stock Exchange
EPS
$3.43
Market Cap
$10.35 B
Shares Outstanding
1.09 B
Public Float
1.09 B

Profile

Address
5 Basel Street
Petach Tikva HM 49131
Israel
Employees -
Website http://www.tevapharm.com
Updated 07/08/2019
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.

Financials

View All
Created with Highcharts 5.0.14Teva Pharmaceutical Industries Ltd.Net Income. Fiscal year is January-December. All values ILS Millions.4 5804 58010 92810 9286 1706 1701 2631 26358 50558 5057 7307 730201320142015201620172018010k20k30k40k50k60k70k
Created with Highcharts 5.0.14Teva Pharmaceutical Industries Ltd.Sales/Revenue. Fiscal year is January-December. All values ILS Millions.73 32473 32472 50672 50676 24476 24484 08084 08080 51880 51867 78567 785201320142015201620172018020k40k60k80k100k

Kåre Schultz
President, Chief Executive Officer & Director
Ronit Satchi-Fainaro
Director